Venture Team Competition

On Tuesday, October 11th, the UCLA Business of Science Center (BSC) will host its 6th annual BSC Venture Team Competition. Throughout the 2015-2016 school year, student Venture Teams evaluated their assigned technology with regard to commercialization potential and provided recommendations regarding a path for commercialization. The finalists (listed below) will deliver a 10-minute investment-style pitch to a panel of experienced judges who will assess the potential of the technologies. The grand prize is $30,000 in proof-of-concept funding to accelerate the technology toward commercialization.

Thanks to UCLA Clinical and Translational Science Institute and  Perkins Coie LLP for making this event possible! For more information visit

The 2016 Venture Team Finalists are: 

1. Scott Kitchen, Ph.D. – Antiviral Tcell Therapy from Stem Cells
Researchers at UCLA have developed a therapeutic technology that combines the advances in gene therapy, stem cell technology and immune therapy. This technology enables the generation of anti-viral T cells from the stem cells of a patient who fails to generate effective anti-viral T cells. This approach involves harnessing stem cells from a patient and delivering into these cells a cloned human T cell receptor gene; the T-cell receptor is the receptor on T cells that recognizes antigens on pathogens and cancers (in this case, the antigen is the HIV gag protein). The modified stem cells will be re-introduced into the patient where the cells would develop into mature, anti-viral T cells that can functionally respond to antigen and produce responses specific to the patients’ infectious profile. 
Student Team: Theodore Kee

2. Neil Martin, MD – Device for Minimally Invasive Rapid Treatment of Intracranial Hemorrhage
Dr. Neil Martin has developed a minimally invasive image-guided cannula for hematoma evacuation from the brain. The cannula is designed to perform both suction and irrigation of the hematoma through a burr hole. With the use of a surgical stereotactic image guidance system and endoscopes, a safe and easy introduction into the hematoma is assured.
Student Team: Nikhilesh Bhatt, Rehan Karmali, Shayan Moazeni, & Shervin Sarji

3. Jau-Nian Chen, Ph.D and Ohyun Kwon, Ph.D. – Efsevin for Arterial Fibrillation
UCLA researchers in the Departments of Molecular, Cell and Developmental Biology and Chemistry and Biochemistry have identified a synthetic compound that possesses potent activity to restore coordinated contractions of the heart. The small molecule has been shown to suppress cardiac fibrillation in vivo by regulating Ca2+ homeostasis, this provides a pharmacological tool with the capacity to restore cardiac rhythmicity.
Student Team: Tiancheng Fang, Shahriyar Jahanbakhs, Binsen Li, & Scott McConnell





Go Metro to this event. Plan your trip on



Take a Lyft to #ILA2016 events this year! New users receive $50 in ride credit with the code: INNOVATELA.

October 11, 2016 at 4pm - 6pm
California Nanosystems Institute (CNSI)
570 Westwood Plz
Los Angeles, CA 90095
United States
Google map and directions
Google Map & Directions
UCLA Business of Science Center · · 310-206-8611